Thermo Fisher Scientific | TMO - Gross Profit On Sales


Thermo Fisher Scientific reported $4.49B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Agilent USD 990M 44M Mar/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 309.4M 35.8M Mar/2026
Boston Scientific USD 3.82B 210M Jun/2026
Bruker USD 416M 36.2M Jun/2026
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Danaher USD 3.61B 20M Jun/2026
Dentsply International USD 493M 66M Jun/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
General Electric Aerospace USD 4.46B 220M Jun/2026
Henry Schein USD 1.03B 39M Jun/2026
Illumina USD 770M 49M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Laboratory Of America USD 1.11B 98.2M Jun/2026
Medtronic USD 6.01B 595M Mar/2026
Mettler Toledo International USD 555.82M 119.62M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Olympus JPY 156.83B 35.93B Jun/2026
OraSure Technologies USD 11.34M 435K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Repligen USD 110.04M 1.75M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
Stryker USD 4.5B 688M Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Veracyte USD 108.55M 7.39M Jun/2026
Waters USD 490M 52M Jun/2026
Zimmer Biomet Holdings USD 1.36B 149.4M Jun/2026